5-羟色胺受体显像剂在神经系统疾病及脑功能研究中的应用

邱春; 管一晖; 邱春; 管一晖

doi:10.3760/cma.j.issn.1673-4114.2011.02.003

[1]

孙凤艳. 医学神经生物学. 上海: 上海科学技术出版社, 2008.

[2]

李国彰. 神经生理学. 北京: 人民卫生出版社, 2007.

[3]

Wang HC, Zuo CT, Guan YH. Research on receptors related to acupuncture analgesia and positron emission tomography radioligands: a review. Zhong Xi Yi Jie He Xue Bao, 2009, 7(6): 575-581. doi: 10.3736/jcim20090615

[4]

Varnäs K, Hall H, Bonaventure P, et al. Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using[(3)H]GR 125743. Brain Res, 2001, 915(1): 47-57. doi: 10.1016/S0006-8993(01)02823-2

[5]

Rosell DR, Thompson JL, Slifstein M, et al. Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol Psychiatry, 2010, 67(12): 1154-1162. doi: 10.1016/j.biopsych.2010.03.013

[6]

Yatham LN, Liddle PF, Erez J, et al. Brain serotonin-2 receptors in acute mania. Br J Psychiatry, 2010, 196(1): 47-51. doi: 10.1192/bjp.bp.108.057919

[7]

Monti JM. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement(REM) sleep. Sleep Med Rev, 2010, 14(5): 319-327. doi: 10.1016/j.smrv.2009.10.003

[8]

Kumar JS, Mann JJ. PET tracers for 5-HT(1A) receptors and uses thereof. Drug Discov Today, 2007, 12 (17-18): 748-756. doi: 10.1016/j.drudis.2007.07.008

[9]

Shiue CY, Shiue GG, Mozley PD, et al. P-[¹⁸F]-MPPF: a potential radioligand for PET studies of 5-HT_1A receptors in humans. Synapse, 1997, 25(2): 147-154. doi: 10.1002/(SICI)1098-2396(199702)25:2<147::AID-SYN5>3.0.CO;2-C

[10]

Passchier J, van Waarde A, Pieterman RM, et al. Quantitative imaging of 5-HT(1A)receptor binding in healthy volunteers with [(18)f]p-MPPF. Nucl Med Biol, 2000, 27(5): 473-476. doi: 10.1016/S0969-8051(00)00114-1

[11]

Defraiteur C, Lemaire C, Luxen A, et al. Radiochemical synthesis and tissue distribution of p-[¹⁸F]DMPPF, a new 5-HT_1A ligand for PET, in rats. Nucl Med Biol, 2006, 33(5): 667-675. doi: 10.1016/j.nucmedbio.2006.03.010

[12]

张现忠, 庞燕, 范卫卫, 等. 一种潜在5-HT_1A脑受体显像剂⁹⁹Tc^m-Bicine/HYNIC-MPP2的制备及其生物性能. 核化学与放射化学, 2009, 31(4): 206-211.

[13]

Passchier J, van Waarde A. Visualisation of serotonin-1A(5-HT_1A) receptors in the central nervous system. Eur J Nucl Med, 2001, 28(1): 113-129. doi: 10.1007/s002590000394

[14]

Lemoine L, Verdurand M, Vacher B, et al. [¹⁸F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging. Eur J Nucl Med Mol Imaging, 2010, 37(3): 594-605. doi: 10.1007/s00259-009-1274-y

[15]

Pierson ME, Andersson J, Nyberg S, et al. [¹¹C]AZ10419369: a selective 5-HT_1B receptor radioligand suitable for positron emission tomography(PET). Characterization in the primate brain. Neuroimage, 2008, 41(3): 1075-1085. doi: 10.1016/j.neuroimage.2008.02.063

[16]

Nabulsi N, Huang Y, Weinzimmer D, et al. High-resolution imaging of brain 5-HT_1B receptors in the rhesus monkey using [¹¹C]P943. Nucl Med Biol, 2010, 37(2): 205-214. doi: 10.1016/j.nucmedbio.2009.10.007

[17]

Ametamey SM, Honer M, Schubiger PA. Molecular imaging with PET. Chem Rev, 2008, 108 (5): 1501-1516. doi: 10.1021/cr0782426

[18]

Debus F, Herth MM, Piel M, et al. ¹⁸F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT_2A antagonists for molecular imaging. Nucl Med Biol, 2010, 37(4): 487-495. doi: 10.1016/j.nucmedbio.2010.02.002

[19]

Marner L, Gillings N, Madsen K, et al. Brain imaging of serotonin 4 receptors in humans with [¹¹C] SB207145-PET. Neuroimage, 2010, 50(3): 855-861. doi: 10.1016/j.neuroimage.2010.01.054

[20]

Xu R, Hong J, Pike VW. Synthesis of high-affinity SB207710 analogs as potential brain 5-HT₄ receptor radioligands for PET imaging. J label Comp Radiopharm, 2009, 52: S425.

[21]

Berney A, Nishikawa M, Benkelfat C, et al. An index of 5-HT synthesis changes during early antidepressant treatment alpha-[¹¹C]methyl-L-tryptophan PET study. Neurochem Int, 2008, 52(4-5): 701-708. doi: 10.1016/j.neuint.2007.08.021

[22]

Huang Y, Hwang DR, Bae SA, et al. A new positron emission to-mography imaging agent for the serotonin transporter synthesis, pharmacological characterization, and kinetic analysis of [¹¹C] 2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylpenylamine([¹¹C]AFM). Nucl Med Biol, 2004, 31(5): 543-556. doi: 10.1016/j.nucmedbio.2003.11.008

[23]

Huang Y, Narendran R, Bae SA, et al. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand[¹¹C]2-[2-dimethylaminomethylphenylthio)]-5-fluo-rophenylamine([¹¹C]AFA). Nucl Med Biol, 2004, 31(5): 727-738.

[24]

Shiue GG, Choi SR, Fang P, et al. N, N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine(4-(18)F-ADAM): an improved PET radioligand for serotonin transporters. J Nucl Med, 2003, 44(12): 1890-1897.

[25]

Praschak-Rieder N, Hussey D, Wilson AA, et al. Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an[(18)F]MPPF positron emission tomography study. Biol Psychiatry, 2004, 56(8): 587-591. doi: 10.1016/j.biopsych.2004.07.018

[26]

Yasuno F, Suhara T, Ichimiya T, et al. Decreased 5-HT_1A receptor binding in amygdala of schizophrenia. Biol Psychiatry, 2004, 55(5): 439-444. doi: 10.1016/j.biopsych.2003.11.016

[27]

Frankle WG, Lombardo I, Kegeles LS, et al. Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [¹¹C] WAY 100635. Psychopharmacology(Berl), 2006, 189(2): 155-164. doi: 10.1007/s00213-006-0543-8

[28]

Rasmussen H, Erritzoe D, Andersen R, et al. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia. Arch Gen Psychiatry, 2010, 67(1): 9-16. doi: 10.1001/archgenpsychiatry.2009.176

[29]

Galusca B, Costes N, Zito NG, et al. Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [¹⁸F] MPPF PET scan study. Biol Psychiatry, 2008, 64(11): 1009-1013. doi: 10.1016/j.biopsych.2008.06.006

[30]

Merlet I, Ryvlin P, Costes N, et al. Statistical parametric mapping of 5-HT_1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. Neuroimage, 2004, 22(2): 886-896. doi: 10.1016/j.neuroimage.2004.02.014

[31]

Kepe V, Barrio JR, Huang SC, et al. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc Natl Acad Sci U S A, 2006, 103(3): 702-707. doi: 10.1073/pnas.0510237103

[32]

Derry C, Benjamin C, Bladin P, et al. Increased serotonin receptor availability in human sleep: evidence from an [¹⁸F]MPPF PET study in narcolepsy. Neuroimage, 2006, 30(2): 341-348. doi: 10.1016/j.neuroimage.2005.09.052